Partner Investment Management as of Dec. 31, 2015
Portfolio Holdings for Partner Investment Management
Partner Investment Management holds 64 positions in its portfolio as reported in the December 2015 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Walgreen Boots Alliance (WBA) | 6.5 | $4.0M | 47k | 85.16 | |
Bristol Myers Squibb (BMY) | 5.5 | $3.4M | 49k | 68.78 | |
Allergan | 5.0 | $3.1M | 9.8k | 312.52 | |
Teva Pharmaceutical Industries (TEVA) | 4.1 | $2.5M | 38k | 65.64 | |
Palo Alto Networks (PANW) | 4.0 | $2.4M | 14k | 176.11 | |
Aercap Holdings Nv Ord Cmn (AER) | 3.5 | $2.1M | 49k | 43.15 | |
Edwards Lifesciences (EW) | 3.0 | $1.9M | 24k | 79.00 | |
Medicines Company | 3.0 | $1.8M | 49k | 37.35 | |
Alphabet Inc Class A cs (GOOGL) | 2.9 | $1.8M | 2.3k | 778.07 | |
Amazon (AMZN) | 2.7 | $1.7M | 2.5k | 676.03 | |
Vulcan Materials Company (VMC) | 2.7 | $1.6M | 17k | 94.99 | |
Jazz Pharmaceuticals (JAZZ) | 2.5 | $1.6M | 11k | 140.53 | |
Charles Schwab Corporation (SCHW) | 2.5 | $1.5M | 46k | 32.92 | |
Alibaba Group Holding (BABA) | 2.4 | $1.4M | 18k | 81.26 | |
Universal Health Services (UHS) | 2.3 | $1.4M | 12k | 119.45 | |
Heron Therapeutics (HRTX) | 2.0 | $1.3M | 47k | 26.69 | |
Clovis Oncology | 2.0 | $1.2M | 35k | 35.01 | |
Alder Biopharmaceuticals | 2.0 | $1.2M | 37k | 33.03 | |
Aerie Pharmaceuticals | 2.0 | $1.2M | 50k | 24.36 | |
Aetna | 2.0 | $1.2M | 11k | 108.08 | |
Acorda Therapeutics | 2.0 | $1.2M | 28k | 42.78 | |
Textron (TXT) | 1.8 | $1.1M | 26k | 42.02 | |
Bristol-myers Squibb | 1.8 | $1.1M | 16k | 68.81 | |
Lam Research Corporation | 1.8 | $1.1M | 13k | 79.45 | |
Synchrony Financial (SYF) | 1.6 | $1.0M | 33k | 30.42 | |
Hologic (HOLX) | 1.6 | $986k | 26k | 38.68 | |
Facebook Inc cl a (META) | 1.5 | $918k | 8.8k | 104.65 | |
Fortune Brands (FBIN) | 1.4 | $832k | 15k | 55.49 | |
Netflix (NFLX) | 1.3 | $817k | 7.1k | 114.33 | |
Molina Healthcare (MOH) | 1.3 | $780k | 13k | 60.13 | |
BlackRock | 1.2 | $735k | 2.2k | 340.44 | |
Bluebird Bio (BLUE) | 1.2 | $721k | 11k | 64.21 | |
Hca Holdings (HCA) | 1.1 | $698k | 10k | 67.64 | |
Servicenow (NOW) | 1.1 | $697k | 8.1k | 86.51 | |
Macquarie Infrastructure Company | 1.1 | $685k | 9.4k | 72.59 | |
Home Depot (HD) | 1.0 | $612k | 4.6k | 132.21 | |
Kite Pharma | 0.9 | $581k | 9.4k | 61.63 | |
Theravance | 0.9 | $542k | 51k | 10.55 | |
Accuray Incorporated (ARAY) | 0.9 | $536k | 79k | 6.75 | |
UnitedHealth (UNH) | 0.9 | $528k | 4.5k | 117.73 | |
Global Blood Therapeutics In | 0.8 | $505k | 16k | 32.30 | |
United Rentals (URI) | 0.8 | $481k | 6.6k | 72.61 | |
Blueprint Medicines (BPMC) | 0.8 | $475k | 18k | 26.31 | |
Microsoft Corporation (MSFT) | 0.8 | $456k | 8.2k | 55.45 | |
Charter Communications | 0.7 | $446k | 2.4k | 183.24 | |
Hortonworks | 0.7 | $407k | 19k | 21.92 | |
Kura Oncology (KURA) | 0.7 | $409k | 49k | 8.39 | |
Rite Aid Corporation | 0.6 | $390k | 50k | 7.84 | |
Celgene Corporation | 0.6 | $389k | 3.2k | 119.73 | |
McKesson Corporation (MCK) | 0.6 | $368k | 1.9k | 197.42 | |
Dex (DXCM) | 0.6 | $344k | 4.2k | 81.98 | |
Zeltiq Aesthetics | 0.6 | $333k | 12k | 28.53 | |
Voyager Therapeutics (VYGR) | 0.5 | $285k | 14k | 19.81 | |
Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.4 | $262k | 437k | 0.60 | |
Myokardia | 0.4 | $229k | 16k | 14.68 | |
Clovis Oncology | 0.3 | $193k | 5.5k | 35.09 | |
Dimension Therapeutics | 0.3 | $196k | 19k | 10.52 | |
AMAG Pharmaceuticals | 0.3 | $189k | 6.3k | 30.16 | |
Gilead Sciences (GILD) | 0.1 | $94k | 933.00 | 100.75 | |
Coherus Biosciences (CHRS) | 0.1 | $91k | 4.0k | 22.95 | |
Atlassian Corp Plc cl a | 0.1 | $49k | 1.6k | 29.82 | |
Juno Therapeutics | 0.1 | $42k | 953.00 | 44.07 | |
Regenxbio Inc equity us cm (RGNX) | 0.1 | $41k | 2.5k | 16.63 | |
MaxLinear (MXL) | 0.0 | $19k | 1.3k | 14.46 |